Clinical Trial Update: Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating pharmacogenomics and SNP guidance for topotecan in small cell lung cancer. The study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | Conditions: SCLC | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING